Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
-
Vornado Realty Trust to Enter into 350 Park Avenue Joint Venture
-
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
-
Artisan Partners Asset Management Inc. Reports July 2026 Assets Under Management
-
Tandy Leather Factory Reports Second Quarter 2026 Results
-
Fabrinet to Present at the Rosenblatt 6th Annual Age of AI Technology Summit
-
Arbor Realty Trust Closes $825 Million Collateralized Loan Obligation Securitization
-
Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2026 Results
-
DoubleDown Interactive Second Quarter 2026 Revenue Rises 11.2% to $94.3 Million and Earnings per Fully Diluted Common Share Increase 50.5% to $13.27
-
Reed’s Reports Second Quarter 2026 Results
-
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
-
Imagine Releases Latest Trends Report, Redefining Retail Therapy: Community, Discovery, Flexibility & Curation in the Physical Store
-
Firefly Aerospace Announces Second Quarter 2026 Financial Results With Record Revenue Of $117.7 Million, Up 659% Year-Over-Year
-
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
-
Imagine Releases Latest Trends Report, Redefining Retail Therapy: Community, Discovery, Flexibility & Curation in the Physical Store
-
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
-
SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
-
Mineralys Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
-
H&R Block Reports Fiscal 2026 Results and Enters Fiscal 2027 with Confidence
-
CNB Financial Corporation Announces Quarterly Dividend for Common Stock
-
Codexis Reports Second Quarter 2026 Financial Results
-
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress
-
Inuvo Announces Planned Financial Leadership Transitions
-
Canterbury Park Holding Corporation Reports Second Quarter Results
-
High Roller Technologies Advances Planned U.S. Prediction Markets Launch; Reports Second Quarter 2026 Results
-
Inuvo Reports Second Quarter 2026 Results
-
Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date July 31, 2026
-
Anterix Inc. Reports First Quarter Fiscal Year 2027 Results
-
Mobia Medical Reports Second Quarter 2026 Financial Results
-
Factorial Announces Second Quarter 2026 Results
-
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
-
Spectral AI Announces 2026 Second Quarter Financial Results
-
Comscore Announces ROI Strategy to Transform the Business
-
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
-
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
-
GrowGeneration Reports Second Quarter 2026 Financial Results
-
Snail, Inc. Reports Second Quarter 2026 Financial Results
-
Black Rock Coffee Bar, Inc. Reports Second Quarter 2026 Results
-
Inuvo Announces Planned Financial Leadership Transitions
-
Seer Reports Second Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
-
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
-
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
-
Firefly Aerospace Announces Extension of Multi-Launch Agreement with Lockheed Martin Through 2031
-
Mobile Infrastructure Reports Second Quarter 2026 Financial Results
-
Hour Loop Reports Second Quarter of 2026 Results
-
Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results
-
IZEA Reports Q2 2026 Revenue of $5.8 million, Advances Enterprise-Focused Growth Strategy
-
Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

